Shandong Sanyuan Biotechnology Co.,Ltd. (SHE:301206)
China · Delayed Price · Currency is CNY 24.93
-0.16 (-0.64%)
May 29, 2026, 3:04 PM CST
SHE:301206 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 92.59 | 91.41 | 104.95 | 55.98 | 163.69 | 535.42 |
Depreciation & Amortization | 73.49 | 73.49 | 66.26 | 59.61 | 38.75 | 25.65 |
Other Amortization | 0.04 | 0.04 | - | - | - | - |
Loss (Gain) From Sale of Assets | -0.07 | -0.07 | - | - | - | 0.59 |
Asset Writedown & Restructuring Costs | - | - | 0.07 | - | 0.21 | 0.01 |
Loss (Gain) From Sale of Investments | -69.88 | -69.88 | -108.58 | -108.86 | -86.15 | -0.26 |
Provision & Write-off of Bad Debts | -0.17 | -0.17 | 0.64 | 0.05 | -0.24 | 0.36 |
Other Operating Activities | 20.53 | 0.16 | - | 0.15 | 5.18 | 1.22 |
Change in Accounts Receivable | 40.43 | 40.43 | -42.17 | -97.92 | 98.13 | -165.73 |
Change in Inventory | -32.15 | -32.15 | -38.38 | -2.53 | 10.21 | -43.95 |
Change in Accounts Payable | -72.88 | -72.88 | -19.7 | 147.99 | -165.77 | 277.22 |
Operating Cash Flow | 44.37 | 22.82 | -13.65 | 57.31 | 84.26 | 642.08 |
Operating Cash Flow Growth | 794.51% | - | - | -31.99% | -86.88% | 195.39% |
Capital Expenditures | -197.09 | -199.15 | -141.76 | -122.99 | -242.67 | -434.37 |
Sale of Property, Plant & Equipment | 0.1 | 0.1 | - | - | - | 0.03 |
Sale (Purchase) of Real Estate | - | - | - | - | -11.47 | - |
Investment in Securities | -964.23 | 439 | 272.65 | -150.04 | -3,096 | - |
Other Investing Activities | 61.28 | 294.89 | 34.78 | -7.05 | 32.9 | -11.58 |
Investing Cash Flow | -1,100 | 534.85 | 165.66 | -280.07 | -3,317 | -445.93 |
Short-Term Debt Issued | - | - | - | - | - | 1 |
Total Debt Issued | - | - | - | - | - | 1 |
Short-Term Debt Repaid | - | - | - | - | - | -1 |
Total Debt Repaid | - | - | - | - | - | -1 |
Issuance of Common Stock | - | 0.4 | - | - | 3,568 | - |
Repurchase of Common Stock | -43.09 | -43.09 | -17.6 | - | - | - |
Common Dividends Paid | -299.55 | -348.65 | -80.9 | -143.16 | -134.88 | - |
Dividends Paid | -299.55 | -348.65 | -80.9 | -143.16 | -134.88 | - |
Other Financing Activities | 23.48 | -0.4 | - | - | -14.7 | 5.22 |
Financing Cash Flow | -319.16 | -391.73 | -98.5 | -143.16 | 3,418 | 5.22 |
Foreign Exchange Rate Adjustments | -2.06 | -1.29 | 2.81 | 1.38 | 24.93 | -1.19 |
Net Cash Flow | -1,377 | 164.64 | 56.32 | -364.54 | 210.57 | 200.18 |
Free Cash Flow | -152.72 | -176.33 | -155.41 | -65.68 | -158.4 | 207.7 |
Free Cash Flow Growth | - | - | - | - | - | 216.60% |
Free Cash Flow Margin | -21.09% | -27.15% | -21.80% | -13.15% | -23.47% | 12.40% |
Free Cash Flow Per Share | -0.78 | -0.89 | -0.77 | -0.33 | -0.79 | 1.37 |
Cash Interest Paid | - | - | - | - | - | 0 |
Cash Income Tax Paid | - | -19.62 | -56.68 | -51.98 | -40.64 | 2.93 |
Levered Free Cash Flow | 208.4 | -1,241 | -395.91 | -116.43 | -432.86 | 146.47 |
Unlevered Free Cash Flow | 208.4 | -1,241 | -395.91 | -116.43 | -432.86 | 146.47 |
Change in Working Capital | -72.17 | -72.17 | -77 | 50.38 | -37.17 | 79.1 |